Shenzhen Techdow Pharmaceutical
China 2 duplicate records merged Updated 9 July 2026
Shenzhen Techdow Pharmaceutical is an API manufacturer based in China. It holds 2 active US drug master files. Its filings concentrate with Health Canada, ARCSA (EC) and INVIMA (CO). Its GMP standing is certified by EMA, MFDS (Korea) and ANVISA (Brazil). Its most recent recorded inspection, by US FDA, closed on 17 September 2019 as VAI.
2
registered plants
1 with an FDA FEI number
34
filings
across 6 regulators
These figures were checked against the regulators' own files on 25 July 2026
Inspections
3 of 3 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.
Inspection history
- 17 September 2019 VAI US FDA
- 23 January 2015 NAI US FDA
- 15 March 2012 NAI US FDA
NAI means no action indicated, VAI means voluntary action indicated, and OAI means
official action indicated.
Registered plants
| Site | FDA FEI |
| SHENZHEN, China | Not on file |
| China, China | 3005599762 |
What they file, and where
Also appears on these molecule pages
Filings and GMP by regulator
| Regulator | Filings | GMP certificates |
| Health Canada | 13 | None |
| ARCSA (EC) | 12 | None |
| INVIMA (CO) | 3 | None |
| EFDA (ET) | 3 | None |
| MINSA (CR) | 2 | None |
| UZPHARM (UZ) | 1 | None |
| EMA | None | 4 |
| MFDS (Korea) | None | 2 |
| ANVISA (Brazil) | None | 1 |
Comparing suppliers?
Choose your molecules and target markets. Shenzhen Techdow Pharmaceutical comes back tiered against every other
supplier able to file there.
Start for free No sales call.
Open risk flags
- The most recent inspection outcome was VAI, on 17 September 2019.
Sources on this page
- FDA
- Drug master files, establishment registration, inspection classifications
- EDQM
- Certificates of suitability
- EudraGMDP and national regulators
- GMP certificates